Background illustration for clinical trials search

Paid Clinical Trials Wisconsin

Discover 1,093 paid clinical trials in Wisconsin. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Philadelphia PA, Tampa FL, Madison WI, Houston TX
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT05568680

Phase1, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Worcester MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase2, Recruiting

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

for
Multiple Sclerosis
Location: Indianapolis IN, Milwaukee WI
Sponsor: Marquette University

Sex: All

Age: 18 - 70+

Code: NCT05735691

Recruiting

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

for
Brain Metastases
Location: Halifax, Boston MA, Quebec, Egg Harbor NJ, Montreal,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03550391

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Peabody MA, Burlington MA, Commack NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase3, Recruiting

Bucillamine Phase 2 Trial in Patients With Cystinuria

for
Cystinuria
Location: Boston MA, Warwick RI, New York NY, Birmingham AL,
Sponsor: Revive Therapeutics, Ltd.

Sex: All

Age: 18 - 70+

Code: NCT02942420

Phase2, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase3, Recruiting

Strategy for Improving Stroke Treatment Response

for
Ischemic Stroke
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Translational Sciences, Inc.

Sex: All

Age: 18+

Code: NCT05948566

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

for
Metastatic Malignant Neoplasm in the Brain,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05222620

Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Popular cities in Wisconsin

The state of Wisconsin offers a substantial healthcare network and renowned medical research institutions, making it a prime location for clinical research into a variety of conditions. Leading centers such as the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and Froedtert Hospital are state leaders in medical research. These institutions, known for their innovative approaches, provide a strong foundation for conducting clinical trials that advance medical knowledge and treatment options.

Why choose Wisconsin for clinical trials?

There are several reasons why researchers conduct clinical trials in Wisconsin. Firstly, the state’s diverse population provides a wide range of participants, which enhances the accuracy and applicability of research outcomes. Wisconsin is also home to a thriving research community, with a strong emphasis on medical innovation and innovative studies that push boundaries.

By choosing to participate in a clinical trial in Wisconsin, you play a crucial role in advancing medical research while benefiting from a well-established and supportive clinical research environment, backed by renowned institutions and expert healthcare professionals.

Common conditions studied in Wisconsin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Wisconsin